Fudim Marat, Cerbin Lukasz P, Devaraj Srikant, Ajam Tarek, Rao Sunil V, Kamalesh Masoor
Department of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Department of Cardiology, Duke University Medical Center, Durham, North Carolina.
Am J Cardiol. 2018 Jul 15;122(2):275-278. doi: 10.1016/j.amjcard.2018.04.007. Epub 2018 Apr 11.
Patients with post-traumatic stress disorder (PTSD) are at risk of multiple co-morbidities and are more likely to develop incident heart failure with reduced ejection fraction (HFrEF). The relation of PTSD with clinical outcomes in HFrEF is not established. US veterans diagnosed with HFrEF from January 2007 to January 2015 and treated nationwide in the Veterans Affairs (VA) Health System were included in the study. Patients with HFrEF were identified through International Classification of Diseases, Ninth Revision (ICD-9) codes. Mortality data were obtained from the VA's death registry. We compared characteristics of patients with HFrEF with and without PTSD. We identified 111,970 VA patients with HFrEF and 11,039 patients with concomitant PTSD (9.9%). Patients with PTSD and HFrEF tended to be younger (64 vs 69 years) and have a higher rate of coronary artery disease (73% vs 64%), chronic obstructive pulmonary disease (42% vs 31%), and hypertension (80% vs 64%, p <0.01 for all variables). Patients with PTSD and HFrEF were more commonly on a high-dose β blocker (70% vs 68%, p <0.01) and angiotensin-converting enzyme inhibitors (96% vs 93%, p <0.01). PTSD was associated with significantly increased mortality at 7 years compared with patients with heart failure without PTSD (adjusted 1.54, 95% confidence interval 1.30 to 1.82, p <0.01). In conclusion, nearly 10% of veterans with HFrEF have PTSD. Patients with HFrEF with PTSD have a higher burden of co-morbidities, and PTSD is associated with a higher rate of all-cause death. Our findings support greater attention to the treatment of patients with PTSD and the causes associated with the poor outcomes.
创伤后应激障碍(PTSD)患者存在多种共病风险,且更易发生射血分数降低的心力衰竭(HFrEF)。PTSD与HFrEF临床结局之间的关系尚未明确。本研究纳入了2007年1月至2015年1月期间在美国退伍军人事务部(VA)医疗系统全国范围内接受治疗、被诊断为HFrEF的美国退伍军人。通过国际疾病分类第九版(ICD - 9)编码识别出HFrEF患者。死亡数据来自VA的死亡登记处。我们比较了有和没有PTSD的HFrEF患者的特征。我们识别出111970例VA的HFrEF患者和11039例伴有PTSD的患者(9.9%)。患有PTSD和HFrEF的患者往往更年轻(64岁对69岁),冠状动脉疾病发生率更高(73%对64%)、慢性阻塞性肺疾病发生率更高(42%对31%)以及高血压发生率更高(80%对64%,所有变量p<0.01)。患有PTSD和HFrEF的患者更常使用高剂量β受体阻滞剂(70%对68%,p<0.01)和血管紧张素转换酶抑制剂(96%对93%,p<0.01)。与没有PTSD的心力衰竭患者相比,PTSD与7年时死亡率显著增加相关(校正后为1.54,95%置信区间1.30至1.82,p<0.01)。总之,近10%的HFrEF退伍军人患有PTSD。患有PTSD的HFrEF患者共病负担更高,且PTSD与全因死亡率更高相关。我们的研究结果支持更关注PTSD患者的治疗以及与不良结局相关的原因。